title: More action, less resistance: report of the 2014 summit of the Global Respiratory Infection Partnership.
abstract: 'Antimicrobial resistance is a global health security threat that requires concerted cross-sectional action by governments and society as a whole,' according to a report published by the WHO in April 2014([1]) . On 24-25 June 2014, the Global Respiratory Infection Partnership (GRIP) met in London, UK, together with delegates from 18 different countries to discuss practical steps that can be taken at a local level to address this global problem in an aligned approach. This was the second annual summit of GRIP. The group, formed in 2012, includes primary care and hospital physicians, microbiologists, researchers, and pharmacists from nine core countries. GRIP aims to unite healthcare professionals (HCPs) around the world to take action against inappropriate antibiotic use, focussing on one of the most prevalent therapy areas where antibiotics are inappropriately prescribed - upper respiratory tract infections (URTIs). Chaired by GRIP member, Professor John Oxford (UK), the 2014 summit included engaging presentations by guest speakers examining the latest science regarding the impact of inappropriate antibiotic use.
authors.affiliation: Institute of General Practice, University of Rostock, Rostock, Germany.
authors.forename: Attila
authors.initials: A
authors.lastname: Altiner
authors.affiliation: Graduate School of Health, University of Technology, Sydney, NSW, Australia.
authors.forename: John
authors.initials: J
authors.lastname: Bell
authors.affiliation: School of Medical Sciences, Bangor University, Bangor.
authors.forename: Martin
authors.initials: M
authors.lastname: Duerden
authors.affiliation: School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
authors.forename: Sabiha
authors.initials: S
authors.lastname: Essack
authors.affiliation: Institute of Antimicrobial Chemotherapy, Smolensk State Medical Academy, Smolensk, Russian Federation.
authors.forename: Roman
authors.initials: R
authors.lastname: Kozlov
authors.affiliation: School of Medicine, National University of Ireland, Galway, Ireland.
authors.forename: Laura
authors.initials: L
authors.lastname: Noonan
authors.affiliation: Queen Mary's School of Medicine and Dentistry, Barts and The London School of Medicine and Dentistry, St Bartholomew's and the Royal London Hospital, Queen Mary's School of Medicine and Dentistry, London, UK.
authors.forename: John
authors.initials: J
authors.lastname: Oxford
authors.affiliation: Department of Medicine, Division of Infectious Diseases, Federal University of Sao Paulo, Sao Paulo, Brazil.
authors.forename: Antonio Carlos
authors.initials: AC
authors.lastname: Pignatari
authors.affiliation: Società Italiana di Medicina Generale, Arcisate, Italy.
authors.forename: Aurelio
authors.initials: A
authors.lastname: Sessa
authors.affiliation: University Medical Center, Utrecht University, Utrecht, The Netherlands.
authors.forename: Alike
authors.initials: A
authors.lastname: van der Velden
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D010818:Practice Patterns, Physicians' / Q000592:standards*; D012141:Respiratory Tract Infections / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents
keywords: OTC medicines; antibiotics; community pharmacy; delivery of care; inappropriate prescribing